Suchergebnisse - "Patiño-Escobar, Bonell"

PubPharm (12)

1

Functional multi-omics reveals genetic and pharmacologic regulation of surface CD38 in multiple myeloma

enthalten in: bioRxiv.org | 2024

von Choudhry, P. | Kasap, C. | Patiño-Escobar, B. | +19

2

CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Wadhwa, A. | Wang, S. | Patiño-Escobar, B. | +20

3

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells

enthalten in: bioRxiv.org | 2024

von Kasap, C. | Izgutdina, A. | Patiño-Escobar, B. | +32

4

Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells

enthalten in: bioRxiv : the preprint server for biology | 2024

von Kasap, C. | Izgutdina, A. | Patiño-Escobar, B. | +32

5

Overcoming proteasome inhibitor resistance in the immunotherapy era

enthalten in: Trends in pharmacological sciences | 2023

von Patiño-Escobar, B. | Talbot, A. | Wiita, A.

6

Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistance

enthalten in: Cell stress | 2022

von Patiño-Escobar, B. | Ferguson, I. | Wiita, A.

CommentOn: Nat Commun. 2022 Jul 15;13(1):4121. - PMID 35840578

7

Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma

enthalten in: Cell chemical biology | 2022

von Ferguson, I. | Lin, Y. | Lam, C. | +17

8

The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance

enthalten in: Nature communications | 2022

von Ferguson, I. | Patiño-Escobar, B. | Tuomivaara, S. | +26

CommentIn: Cell Stress. 2022 Oct 13;6(11):89-92. - PMID 36311892

9

FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma

enthalten in: Blood advances | 2021

von Bigley, A. | Spade, S. | Agha, N. | +13

10

CD38 : From Positive to Negative Expression after Daratumumab Treatment

enthalten in: Cureus | 2020

von Patiño-Escobar, B. | Ramos, R. | Linares, M. | +2